Go Pro

Nature's Sunshine Products (NATR) Competitors

Nature's Sunshine Products logo
$20.43 -0.90 (-4.22%)
Closing price 04:00 PM Eastern
Extended Trading
$20.40 -0.03 (-0.14%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NATR vs. HLF, USNA, NUS, MED, and VERU

Should you buy Nature's Sunshine Products stock or one of its competitors? MarketBeat compares Nature's Sunshine Products with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nature's Sunshine Products include Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Medifast (MED), and Veru (VERU). These companies are all part of the "personal products" industry.

How does Nature's Sunshine Products compare to Herbalife?

Herbalife (NYSE:HLF) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

Herbalife has a net margin of 4.67% compared to Nature's Sunshine Products' net margin of 4.06%. Nature's Sunshine Products' return on equity of 14.67% beat Herbalife's return on equity.

Company Net Margins Return on Equity Return on Assets
Herbalife4.67% -41.47% 8.24%
Nature's Sunshine Products 4.06%14.67%9.27%

79.4% of Nature's Sunshine Products shares are held by institutional investors. 5.1% of Herbalife shares are held by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Herbalife had 4 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 5 mentions for Herbalife and 1 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.89 beat Herbalife's score of 0.79 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Herbalife
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Herbalife has higher revenue and earnings than Nature's Sunshine Products. Herbalife is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Herbalife$5.04B0.25$228.30M$2.285.27
Nature's Sunshine Products$480.14M0.75$19.52M$1.1018.57

Herbalife currently has a consensus target price of $17.80, suggesting a potential upside of 48.25%. Nature's Sunshine Products has a consensus target price of $35.00, suggesting a potential upside of 71.32%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts clearly believe Nature's Sunshine Products is more favorable than Herbalife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Herbalife
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Herbalife has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

Summary

Nature's Sunshine Products beats Herbalife on 10 of the 17 factors compared between the two stocks.

How does Nature's Sunshine Products compare to USANA Health Sciences?

USANA Health Sciences (NYSE:USNA) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

Nature's Sunshine Products has a consensus price target of $35.00, suggesting a potential upside of 71.32%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Nature's Sunshine Products has a net margin of 4.06% compared to USANA Health Sciences' net margin of 0.96%. Nature's Sunshine Products' return on equity of 14.67% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences0.96% 6.21% 4.50%
Nature's Sunshine Products 4.06%14.67%9.27%

In the previous week, USANA Health Sciences had 3 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 4 mentions for USANA Health Sciences and 1 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.89 beat USANA Health Sciences' score of 0.52 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
USANA Health Sciences
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Nature's Sunshine Products has lower revenue, but higher earnings than USANA Health Sciences. Nature's Sunshine Products is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$925.26M0.44$10.76M$0.4746.48
Nature's Sunshine Products$480.14M0.75$19.52M$1.1018.57

USANA Health Sciences has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Summary

Nature's Sunshine Products beats USANA Health Sciences on 14 of the 17 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Nu Skin Enterprises?

Nature's Sunshine Products (NASDAQ:NATR) and Nu Skin Enterprises (NYSE:NUS) are both small-cap personal products companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

79.4% of Nature's Sunshine Products shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 3.1% of Nature's Sunshine Products shares are held by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Nature's Sunshine Products has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market.

Nature's Sunshine Products currently has a consensus target price of $35.00, suggesting a potential upside of 71.32%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, research analysts plainly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Nature's Sunshine Products has a net margin of 4.06% compared to Nu Skin Enterprises' net margin of 3.78%. Nature's Sunshine Products' return on equity of 14.67% beat Nu Skin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Nature's Sunshine Products4.06% 14.67% 9.27%
Nu Skin Enterprises 3.78%7.47%4.21%

In the previous week, Nature's Sunshine Products had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 1 mentions for Nature's Sunshine Products and 0 mentions for Nu Skin Enterprises. Nature's Sunshine Products' average media sentiment score of 1.89 beat Nu Skin Enterprises' score of 0.00 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company Overall Sentiment
Nature's Sunshine Products Very Positive
Nu Skin Enterprises Neutral

Nu Skin Enterprises has higher revenue and earnings than Nature's Sunshine Products. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nature's Sunshine Products$480.14M0.75$19.52M$1.1018.57
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.76

Summary

Nature's Sunshine Products beats Nu Skin Enterprises on 12 of the 16 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Medifast?

Medifast (NYSE:MED) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

Medifast has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

Medifast currently has a consensus target price of $12.00, suggesting a potential upside of 17.03%. Nature's Sunshine Products has a consensus target price of $35.00, suggesting a potential upside of 71.32%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than Medifast.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medifast
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Nature's Sunshine Products has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medifast$385.79M0.30-$18.67M-$1.83N/A
Nature's Sunshine Products$480.14M0.75$19.52M$1.1018.57

95.5% of Medifast shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 3.7% of Medifast shares are owned by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Medifast had 4 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 5 mentions for Medifast and 1 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.89 beat Medifast's score of 1.21 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medifast
1 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Nature's Sunshine Products has a net margin of 4.06% compared to Medifast's net margin of -5.78%. Nature's Sunshine Products' return on equity of 14.67% beat Medifast's return on equity.

Company Net Margins Return on Equity Return on Assets
Medifast-5.78% -4.80% -3.83%
Nature's Sunshine Products 4.06%14.67%9.27%

Summary

Nature's Sunshine Products beats Medifast on 13 of the 16 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Veru?

Veru (NASDAQ:VERU) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M2.26-$22.73M-$0.89N/A
Nature's Sunshine Products$480.14M0.75$19.52M$1.1018.57

Veru has a beta of -1.19, indicating that its share price is 219% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

47.2% of Veru shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 14.2% of Veru shares are held by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Veru and Veru both had 1 articles in the media. Nature's Sunshine Products' average media sentiment score of 1.89 beat Veru's score of 0.94 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veru
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Veru presently has a consensus target price of $23.00, suggesting a potential upside of 866.39%. Nature's Sunshine Products has a consensus target price of $35.00, suggesting a potential upside of 71.32%. Given Veru's higher probable upside, research analysts clearly believe Veru is more favorable than Nature's Sunshine Products.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Nature's Sunshine Products has a net margin of 4.06% compared to Veru's net margin of 0.00%. Nature's Sunshine Products' return on equity of 14.67% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
VeruN/A -54.72% -39.09%
Nature's Sunshine Products 4.06%14.67%9.27%

Summary

Nature's Sunshine Products beats Veru on 12 of the 16 factors compared between the two stocks.

Get Nature's Sunshine Products News Delivered to You Automatically

Sign up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NATR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NATR vs. The Competition

MetricNature's Sunshine ProductsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$375.08M$3.03B$6.90B$12.43B
Dividend YieldN/A2.06%2.67%8.84%
P/E Ratio18.5719.9127.1723.89
Price / Sales0.75350.00526.2192.04
Price / Cash9.8157.2151.4660.07
Price / Book2.214.2610.696.18
Net Income$19.52M$65.46M$3.59B$331.73M
7 Day Performance-3.95%-3.18%-2.17%-2.29%
1 Month Performance1.74%0.73%2.08%-1.62%
1 Year Performance39.17%17.34%24.68%16.81%

Nature's Sunshine Products Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NATR
Nature's Sunshine Products
3.4664 of 5 stars
$20.43
-4.2%
$35.00
+71.3%
+40.2%$375.08M$480.14M18.57850
HLF
Herbalife
4.317 of 5 stars
$12.27
-6.3%
$17.80
+45.0%
+35.8%$1.36B$5.04B5.388,500
USNA
USANA Health Sciences
2.3118 of 5 stars
$21.41
-2.8%
N/A-27.5%$406.74M$925.26M45.551,570
NUS
Nu Skin Enterprises
2.3234 of 5 stars
$5.00
-5.2%
N/A-34.7%$255.86M$1.49B4.542,800
MED
Medifast
4.0326 of 5 stars
$10.62
-3.8%
$12.00
+13.0%
-22.4%$122.64M$385.79MN/A870

Related Companies and Tools


This page (NASDAQ:NATR) was last updated on 7/17/2026 by MarketBeat.com Staff.
From Our Partners